Page 397 - IJB-9-1

OUR JOURNALS

Cancer Plus is a new research journal that aims to provide a peer-reviewed,
open access platform for researchers and practitioners to present novel and
high-impact articles in the field of cancer research and clinical trials. This
journal is a joint collaboration between Whioce Publishing Pte. Ltd.
(Singapore) and the Chinese Academy of Sciences (China). Areas of interest
for this journal include, but are not limited to, the following topics:

• Mechanisms of tumorigenesis
• Genetic alterations of cancer
• Epigenetics of cancer
• Cell signalling
• Cancer stem cells
• Cancer prevention
• Diagnosis
• Cancer drugs / chemotherapy / therapeutic methods
• Clinical trials

The Journal of Clinical and Translational Research is an open access, peer-
reviewed, multidisciplinary scientific journal that publishes studies with at least
an ex vivo, in vivo, or clinical component. The published research is centered
on any clearly defined clinical problem, which may comprise a disease or the
basis of disease, a form of therapy or intervention, and clinical diagnostics or
prognostics. Articles (original research, reviews, technical reports, medical
hypotheses, commissioned articles, special issue articles, and editorials) are
published continuously online. The key features of this journal are:
• Open access
• No submission or publication fees
• Reputable international editorial board
• Easy and fast submissions - no formatting rules (“your paper, your
way”)
• No word count or reference restrictions
• Double blind review process to minimize bias
• Rapid online publication of articles upon acceptance
• Outlet for academic institutions and industry

Start a new journal

Write to us via email if you are interested to start a new journal with Whioce Publishing. Please
attach your CV, professional profile page and a brief pitch proposal in your email. We shall inform
you of our decision whether we are interested to collaborate in starting a new journal.
Contact: info@whioce.com